CVE-2019-4291

CVE-2019-4291 is a medium-severity vulnerability in Ibm Maximo Anywhere with a CVSS 3.x base score of 6.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-326.

Key facts

Description

IBM Maximo Anywhere 7.6.4.0 could allow an attacker to reverse engineer the application due to the lack of binary protection precautions. IBM X-Force ID: 160697.

Frequently asked questions

What is CVE-2019-4291?
IBM Maximo Anywhere 7.6.4.0 could allow an attacker to reverse engineer the application due to the lack of binary protection precautions. IBM X-Force ID: 160697.
How severe is CVE-2019-4291?
CVE-2019-4291 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2019-4291 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (35th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2019-4291?
CVE-2019-4291 affects Ibm Maximo Anywhere. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2019-4291?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2019-4291 published?
CVE-2019-4291 was published on 2022-02-16 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Ibm Maximo Anywhere

All CVEs affecting Ibm Maximo Anywhere →

Other CWE-326 (Inadequate Encryption Strength) vulnerabilities

Browse all CWE-326 (Inadequate Encryption Strength) vulnerabilities →